Published on
September 24, 2019
- 23:05 GMT
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
For Immediate Release: September 24, 2019 The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount …
Distribution channels:
Healthcare & Pharmaceuticals Industry
